HISTEX-DM New Formulation
NDC 28595-310, DEXTROMETHORPHAN HBr, PSEUDOEPHEDRINE HCI, and TRIPROLIDINE HCI, syrup, from Allegis Pharmaceuticals, LLC.
- Product NDC
- 28595-310
- Status
- Listed
- Labeler
- Allegis Pharmaceuticals, LLC
- Dosage form
- SYRUP
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M012
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/28595-310 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DEXTROMETHORPHAN HYDROBROMIDE20 mg/5mL
- PSEUDOEPHEDRINE HYDROCHLORIDE30 mg/5mL
- TRIPROLIDINE HYDROCHLORIDE2.5 mg/5mL
Pharmacologic classes
Adrenergic alpha-Agonists [MoA]; Sigma-1 Agonist [EPC]; Sigma-1 Receptor Agonists [MoA]; Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]; Uncompetitive NMDA Receptor Antagonists [MoA]; alpha-Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 28595-310-16 | 28595031016 | 473 mL in 1 BOTTLE (28595-310-16) |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 28595-310 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/28595-310 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 28595-310. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.